Literature DB >> 26416871

Impact of Hydroxychloroquine-Loaded Polyurethane Intravaginal Rings on Lactobacilli.

Yannick Leandre Traore1, Yufei Chen1, Anne-Marie Bernier2, Emmanuel A Ho3.   

Abstract

The use of polymeric devices for controlled sustained delivery of drugs is a promising approach for the prevention of HIV-1 infection. Unfortunately, certain microbicides, when topically applied vaginally, may be cytotoxic to vaginal epithelial cells and the protective microflora present within the female genital tract. In this study, we evaluated the impact of hydroxychloroquine (HCQ)-loaded, reservoir-type, polyurethane intravaginal rings (IVRs) on the growth of Lactobacillus crispatus and Lactobacillus jensenii and on the viability of vaginal and ectocervical epithelial cells. The IVRs were fabricated using hot-melt injection molding and were capable of providing controlled release of HCQ for 24 days, with mean daily release rates of 17.01 ± 3.6 μg/ml in sodium acetate buffer (pH 4) and 29.45 ± 4.84 μg/ml in MRS broth (pH 6.2). Drug-free IVRs and the released HCQ had no significant effects on bacterial growth or the viability of vaginal or ectocervical epithelial cells. Furthermore, there was no significant impact on the integrity of vaginal epithelial cell monolayers, in comparison with controls, as measured by transepithelial electrical resistance. Overall, this is the first study to evaluate the effects of HCQ-loaded IVRs on the growth of vaginal flora and the integrity of vaginal epithelial cell monolayers.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26416871      PMCID: PMC4649168          DOI: 10.1128/AAC.01819-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

2.  In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.

Authors:  Youssef Gali; Olivier Delezay; Joachim Brouwers; Noura Addad; Patrick Augustijns; Thomas Bourlet; Hind Hamzeh-Cognasse; Kevin K Ariën; Bruno Pozzetto; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

3.  The medroxyprogesterone acetate intravaginal silastic ring as a contraceptive device.

Authors:  M Thiery; D Vandekerckhove; M Dhont; A Vermeulen; J M Decoster
Journal:  Contraception       Date:  1976-05       Impact factor: 3.375

Review 4.  Advanced topical drug delivery system for the management of vaginal candidiasis.

Authors:  Himmat Singh Johal; Tarun Garg; Goutam Rath; Amit Kumar Goyal
Journal:  Drug Deliv       Date:  2014-06-24       Impact factor: 6.419

5.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

7.  Reduction of immune activation with chloroquine therapy during chronic HIV infection.

Authors:  Shannon M Murray; Carrie M Down; David R Boulware; William M Stauffer; Winston P Cavert; Timothy W Schacker; Jason M Brenchley; Daniel C Douek
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

Review 8.  Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.

Authors:  D E Furst
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

9.  Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.

Authors:  Alamelu Mahalingam; Adam P Simmons; Shweta R Ugaonkar; Karen M Watson; Charlene S Dezzutti; Lisa C Rohan; Robert W Buckheit; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

Review 10.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.

Authors:  Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2007-07-16       Impact factor: 5.283

View more
  5 in total

1.  Fused deposition modeling three-dimensional printing of flexible polyurethane intravaginal rings with controlled tunable release profiles for multiple active drugs.

Authors:  Yufei Chen; Yannick L Traore; Lyndon Walker; Sidi Yang; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2022-02-24       Impact factor: 4.617

Review 2.  The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings.

Authors:  Louise Carson; Ruth Merkatz; Elena Martinelli; Peter Boyd; Bruce Variano; Teresa Sallent; Robert Karl Malcolm
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

Review 3.  Sustained Release Drug Delivery Applications of Polyurethanes.

Authors:  Michael B Lowinger; Stephanie E Barrett; Feng Zhang; Robert O Williams
Journal:  Pharmaceutics       Date:  2018-05-09       Impact factor: 6.321

Review 4.  In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations-A Critical Review.

Authors:  Katharina Tietz; Sandra Klein
Journal:  Pharmaceutics       Date:  2019-10-16       Impact factor: 6.321

5.  Segmented intravaginal ring for the combination delivery of hydroxychloroquine and anti-CCR5 siRNA nanoparticles as a potential strategy for preventing HIV infection.

Authors:  Yannick L Traore; Yufei Chen; Fernanda Padilla; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2021-04-17       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.